Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01761799 · ClinicalTrials.gov registry record · NA
Protecting Pregnant Women From Infectious Diseases
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 330
- Enrollment target
NCT01761799 is a NA study that has completed, run by Emory University. The registered enrollment target is 330 participants.
The verdict
NCT01761799, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
Study Summary
The primary research aim of this project is to test the effectiveness of a comprehensive, evidence-based vaccine promotion package implemented in the obstetric setting on increasing the likelihood that a pregnant woman in Georgia will receive an influenza and/or pertussis vaccine.
Interventions
- BEHAVIORAL P3 Vaccine Promotion Package.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01761799
The ClinicalTrials.gov registry entry for NCT01761799 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which P3 Vaccine Promotion Package. is the first listed.
NCT01761799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01761799 about?
NCT01761799 is a clinical study titled "Protecting Pregnant Women From Infectious Diseases". The primary research aim of this project is to test the effectiveness of a comprehensive, evidence-based vaccine promotion package implemented in the obstetric setting on increasing the likelihood that a pregnant woman in Georgia will receive an influenza and/or pertussis vaccine.
What is the current status of trial NCT01761799?
This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2012-12. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01761799?
The interventions under investigation include: P3 Vaccine Promotion Package. (BEHAVIORAL).
Who is sponsoring clinical trial NCT01761799?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.